Open AccessAssessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients
Author(s) -
Raj Kumar Badam,
Jyotsna Suram,
Dara Balaji Gandhi Babu,
Shefali Waghray,
Rahul Marshal,
Sharath Chandra Bontha,
Reddy Lavanya,
Sudheer Kanth
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/16091.7121
Subject(s) - medicine , thyroid , scintigraphy , salivary gland , radiation therapy , radioactive iodine , nuclear medicine , iodine , thyroidectomy , submandibular gland , carcinoma , urology , pathology , chemistry , organic chemistry
Thyroid carcinoma represents less than 1% of all cancers. The first line of treatment for thyroid cancer is partial/total thyroidectomy. High-dose Iodine(131) therapy using Iodine radioisotopes is commonly used in patients with well differentiated thyroid carcinoma after total thyroidectomy. In this process, the non-thyroidal tissues, such as, salivary gland, stomach and breast tissues also take up radioactive iodine. Salivary gland scintigraphy is widely accepted as a sensitive and valid method for evaluation of salivary gland dysfunction after Radioactive Iodine(131) Therapy (RIT).